Crossmark Global Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Crossmark Global Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,160	Closed	-$257K	–	1272
2019 Q4	$257K	Buy	+4,160	New	+$276K	0.01%	1200
2018 Q3	–	Sell	-3,520	Closed	-$235K	–	1592
2018 Q2	$235K	Buy	+3,520	New	+$220K	0.01%	1460
2018 Q1	–	Sell	-3,360	Closed	-$217K	–	1579
2017 Q4	$217K	Sell	3,360 -940	-22%	-$58.5K	0.01%	1547
2017 Q3	$226K	Buy	+4,300	New	+$205K	0.01%	1498
2016 Q3	$226K	Buy	+4,300	New	+$269K	0.01%	1498

Other funds holding ANIP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

First Manhattan

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return